TDC Launches Alliance Management at UHN
Technology Development and Commercialization (TDC) is pleased to announce the arrival of Christina von Gemmingen as a Licensing Professional and Alliance Manager.
Christina’s arrival also signals the launch of an alliance management approach at TDC that brings a new level of sophistication to the management of partner relationships between industry and our research community.
Christina von Gemmingen, TDC’s new Licensing Professional/Alliance Manager.
In this role, Christina will maintain a strategic overview of contracts with our industry partners, and help ensure the success of these partnerships by aligning internal and external stakeholders on all significant milestones and changes throughout the partnership.
This alliance management approach will help serve UHN partners as well as external partners by maximizing the strategic and financial value of collaborations, while enabling conflict resolution and governance. Christina will serve as a dedicated first point of contact for researchers and partners and will oversee successful execution of milestones and other operational activities, such as participation on steering committees.
In her dual position of Licensing Professional and Alliance Manager, she is responsible for the alliances of several key industry partners including BlueRock Therapeutics, Inc. and is responsible for negotiating and executing research/licensing agreements for UHN’s McEwen Stem Cell Institute.
Christina earned a B.Sc. from the University of Toronto and has more than 25 years of experience in the pharmaceutical industry, including R&D, the regulatory space, and global business development and licensing. She has worked for both generic and large innovator companies as well as in several countries including the Fiji Islands, New Zealand, Germany and the Netherlands before returning to her hometown of Toronto. Join us in welcoming her to UHN.